Prostate cancer outcomes improved by better targeting increased radiation doses and combining treatments
This article was originally published in Clinica
The outcomes of external radiation therapy for prostate cancer can be improved by combining treatments, increasing dose and more accurately targeting tumours, according to the latest clinical studies. The data were presented at the American Society for Therapeutic Radiology and Oncology (ASTRO) meeting in San Antonio, Texas, last week.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.